Rohit Vikram Tejwani, MD
Urology · North Adams
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations · Berkshire Faculty Services Inc · Duke Health Integrated Practice Inc
Hospitals listed: Duke Regional Hospital · Duke University Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Tejwani’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A187987 · Current
Licensed to practise in California · since 2023 · expires 2027-07-31 · Duke University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Duke Regional HospitalDurham, NCAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Duke University Health System, which runs 3 hospitalsPatients rate it 4 of 5 · 76% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.245, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.204, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0, Oct 2024 – Sep 2025
- Duke University HospitalDurham, NCAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of Duke University Health System, which runs 3 hospitalsHome of Duke Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Death rate among surgical inpatients with serious treatable complications: 216.01 (186.77 to 245.25) · 366 cases, Jul 2022 – Jun 2024Worse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.5 (4.26 to 6.75) · 6,581 cases, Jul 2022 – Jun 2024Worse than the national rate — Postoperative acute kidney injury requiring dialysis rate: 2.95 (2.11 to 3.79) · 3,680 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.374, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.727, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.398, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.592, Oct 2024 – Sep 2025Better than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 8.6 (7.5 to 9.8) · 2,101 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Duke Regional Hospital
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 3 better, 4 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.245 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.204 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.12 (0.12 to 2.12) · 931 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.65 to 1.31) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 134.57 (80.4 to 188.74) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.3 · 138 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.5 · 109 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.7 · 363 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.4 · 327 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.5 · 239 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.5 · 3,382 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.01 to 0.44) · 5,561 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.06 to 0.45) · 5,533 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.2 (2.09 to 6.31) · 1,215 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.91 (0.28 to 3.55) · 472 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.62 (1.09 to 4.16) · 1,088 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.07 (1.89 to 16.25) · 503 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.64 (0.88 to 8.4) · 468 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.18 to 3.16) · 234 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0 to 1.18) · 4,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 96 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.566 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.305 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.4 · 165 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.3 · 792 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 7.2 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -14.5 · 400 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -15.4 · 348 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.4 · 578 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5 (3.3 to 7.5) · 80 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.3 (8.8 to 16.6) · 80 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.5 · 98 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.6 · 283 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.2 (8.7 to 14.8) · 1,346 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 504 cases | No different | Jan 2024 – Dec 2024 |
What patients said (604 patients answered, 19% of those asked)
| Cleanliness | 2 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 59% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 84% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 79% |
| Doctors "always" listened carefully | 84% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Duke University Hospital
Behind the star rating — Deaths: 4 better, 3 the same, 1 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 8 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 216.01 (186.77 to 245.25) · 366 cases | Worse | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.5 (4.26 to 6.75) · 6,581 cases | Worse | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.95 (2.11 to 3.79) · 3,680 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.374 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.727 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.398 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.592 | Better | Oct 2024 – Sep 2025 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 8.6 (7.5 to 9.8) · 2,101 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.91 (0.21 to 1.61) · 4,083 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.1 (0.94 to 1.26) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.6 · 277 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 175 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.4 · 351 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.1 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 9.6 · 530 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.4 · 684 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.3 · 10,510 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.32) · 15,279 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.04 to 0.36) · 16,992 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.62 (1.69 to 3.56) · 5,880 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.88 (6.29 to 11.47) · 3,482 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (4.07 to 7.84) · 3,644 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.49 (1.26 to 3.72) · 1,495 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.5 (0.15 to 0.85) · 14,819 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.9 · 293 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 1.373 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.048 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 12.7 · 688 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.6 · 1,551 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 7.3 · 428 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -20.2 · 963 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -14.2 · 554 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.9 · 861 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.9 (4.1 to 5.8) · 2,101 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.9 · 320 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.7 · 312 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.1 · 367 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.2 to 16) · 2,489 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1) · 2,623 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,341 patients answered, 22% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 90% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 82% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 78% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 58% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
Original Medicare doctor bills
$30,072
Medicare paid this office $30,072 for 170 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| New patient visit (45+ min) | 59 | $5,634 | $95 |
| Return visit (30+ min) | 45 | $3,148 | $66 |
| Diagnostic exam of bladder and urethra using an endoscope | 47 | $2,683 | $57 |
| Long return visit (40+ min) | 20 | $2,152 | $108 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,156 | $96 |
See all 8 services
| New patient visit (45+ min) | 59 | $5,634 | $95 |
| Return visit (30+ min) | 45 | $3,148 | $66 |
| Diagnostic exam of bladder and urethra using an endoscope | 47 | $2,683 | $57 |
| Long return visit (40+ min) | 20 | $2,152 | $108 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,156 | $96 |
| Insertion of stent in ureter using an endoscope | 11 | $991 | $90 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 52 | $716 | $12 |
| Imaging of urinary tract following injection of a contrast agent | 13 | $266 | $19 |
Procedures Medicare counted
| Prostate resection | 45 | More than 96% of doctors who do this |
Who their Medicare patients are
170 Original Medicare patients in 2024. Average age 74 · Women 29% · Also on Medicaid 17% · Health risk score 1.43. Above the middle of the specialty; the typical urology clinician is at 1.36.
Conditions among them: High blood pressure 75% · Coronary heart disease 34% · Chronic kidney disease 33% · Diabetes 29% · Atrial fibrillation 26% · Cancer 24% · Heart failure 18% · Depression 16% · COPD 9% · Dementia 9% · Stroke 9%.
The office billed $319,743, Medicare allowed $40,442 and paid $30,072; for 354 services of 41 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 170 | 354 | 74 | 1.43 | $319,743 | $30,072 |
| 2023 | 66 | 84 | 75 | 1.78 | $99,517 | $8,720 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| New patient visit (45+ min) | 21 | $2,519 | $120 |
| Return visit (30+ min) | 17 | $1,500 | $88 |
| New patient visit (30+ min) | 12 | $888 | $74 |
Drugs they prescribed that Part D paid
$20,004
Pharmacies billed $20,004 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
147 generic and 22 brand-name prescriptions · $20,004 in drug cost · 50 antibiotic prescriptions to 40 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Myrbetriq | 17 | $11,124 | $654 |
| Tamsulosin | 42 | $783 | $19 |
| Finasteride | 15 | $209 | $14 |
| Amoxicillin-Clavulanate Potass | 15 | $55 | $4 |
Year by year
| 2024 | 169 | 77 | None | 13% | $20,004 |
| 2023 | 165 | 90 | 18% (29) | None | $8,502 |
| 2022 | 35 | 21 | None | None | $1,200 |
| 2021 | 150 | 65 | 21% (31) | None | $6,968 |
| 2020 | 128 | 66 | 30% (38) | None | $810 |
| 2019 | 230 | 99 | 24% (54) | None | $3,362 |
| 2018 | 193 | 68 | 20% (38) | 9% | $5,842 |
| 2017 | 66 | 18 | 20% (13) | None | $2,108 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Tamsulosin | 37 | $369 | $10 |
| Oxybutynin Chloride | 23 | $115 | $5 |
| Amoxicillin-Clavulanate Potass | 12 | $68 | $6 |
| Oxycodone | 28 | $61 | $2 |
2021: 4 drugs
| Potassium Citrate Er | 14 | $4,770 | $341 |
| Tamsulosin | 31 | $299 | $10 |
| Oxybutynin Chloride | 34 | $188 | $6 |
| Oxycodone | 21 | $105 | $5 |
2020: 3 drugs
| Oxybutynin Chloride | 28 | $141 | $5 |
| Oxycodone | 26 | $102 | $4 |
| Tamsulosin | 15 | $85 | $6 |
2019: 7 drugs
| Oxybutynin Chloride | 55 | $420 | $8 |
| Tamsulosin | 30 | $258 | $9 |
| Oxycodone | 30 | $155 | $5 |
| Finasteride | 11 | $124 | $11 |
| Hydrocodone-Acetaminophen | 18 | $82 | $5 |
| Ciprofloxacin | 12 | $47 | $4 |
| Gabapentin | 14 | $42 | $3 |
2018: 7 drugs
| Enoxaparin | 16 | $2,613 | $163 |
| Polyethylene Glycol 3350 | 22 | $471 | $21 |
| Gabapentin | 23 | $290 | $13 |
| Oxycodone | 30 | $191 | $6 |
| Oxybutynin Chloride | 20 | $164 | $8 |
| Celecoxib | 11 | $134 | $12 |
| Ciprofloxacin | 12 | $56 | $5 |
2017: 1 drug
| Gabapentin | 11 | $52 | $5 |
Money from drug and device companies
$6,677 in 2025
| 2025 | 9 | 17 | $4,545 | $6,677 |
| 2024 | 7 | 28 | None | $3,498 |
| 2023 | 6 | 32 | None | $3,275 |
| 2022 | 1 | 1 | None | $146 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Cook | S~Curve | $4,568 | 2 payments
|
| Cook Medical | S~Curve | $953 | 3 payments
|
| Calyxo | Cvac Aspiration System | $303 | 3 payments
|
| Boston Scientific | Ams 700 | $262 | 2 payments
|
| Procept Biorobotics | Aquabeam Robotic System | $199 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | None | $135 | 1 payment
|
See all 17 published payments
| Janssen Biotech | Meals · 2025-12-16 | Erleada | $67 |
| Calyxo | Meals · 2025-11-20 | Cvac Aspiration System | $133 |
| Sumitomo Pharma America | Meals · 2025-10-28 | Orgovyx | $24 |
| Boston Scientific | Meals · 2025-10-28 | Lithovue Elite | $109 |
| Calyxo | Meals · 2025-09-10 | Cvac Aspiration System | $137 |
| Procept Biorobotics | Meals · 2025-08-28 | Aquabeam Robotic System | $199 |
| Teleflex | Meals · 2025-08-26 | Barrigel | $109 |
| Janssen Biotech | Meals · 2025-08-12 | Erleada | $30 |
| Cook Medical | Meals · 2025-07-30 | Litho 150 | $84 |
| Cook | Paid to speak or teach · 2025-07-17 | S~Curve | $4,545 |
| Cook | Travel · 2025-07-17 | S~Curve | $23 |
| Cook Medical | Travel · 2025-06-08 | S~Curve | $281 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-19 | None | $135 |
| Cook Medical | Travel · 2025-05-01 | S~Curve | $588 |
| Janssen Biotech | Meals · 2025-03-27 | Erleada | $28 |
| Calyxo | Meals · 2025-03-18 | Cvac Aspiration System | $33 |
| Boston Scientific | Meals · 2025-03-13 | Ams 700 | $153 |
See earlier years (2024, 2023, 2022)
2024: $3,498
| Teleflex | Urolift | $1,530 | 4 payments
|
| Olympus Corporation of the Americas | Cysto-Nephro Videoscope | $649 | 9 payments
|
| PROCEPT BioRobotics | Aquabeam System | $624 | 5 payments
|
| Boston Scientific | Moses 550 Dfl | $304 | 3 payments
|
| Medical Device Business Services | None | $150 | 1 payment
|
| Cook Medical | Litho 150 | $136 | 1 payment
|
| Axonics | Axonics | $105 | 1 payment
|
2023: $3,275
| Coloplast | Titan | $1,357 | 13 payments
|
| PROCEPT BioRobotics | Aquabeam Robotic System | $682 | 7 payments
|
| Cook Medical | Cook | $530 | 8 payments
|
| Cook | S~Curve | $504 | 2 payments
|
| Innovation Technologies | Irrisept | $109 | 1 payment
|
| Sun Pharmaceutical Industries | None | $94 | 1 payment
|
2022: $146
| Medtronic | Interstim | $146 | 1 payment
|
Professional record
- NPI
- 1538693155
- Licence
- CA A187987California A187987: Current · expires 2027-07-31
- Trained
- Duke University School of Medicine, 2017
- Group
- Berkshire Faculty Services Inc · Duke Health Integrated Practice Inc
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Urology (208800000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2017-04-20
- NPI last updated
- 2024-03-14
- NPI record certified
- 2024-03-14
This is when the NPI record was last certified, not a medical board exam.